Linda Montanari
Biographic Data
| ID | 6085675 |
|---|---|
| NAME | Linda Montanari |
| GIVEN NAMES | Linda |
| FAMILY NAME | Montanari |
| SIGNATURE | MONTANARI L |
| AFFILIATIONS | European Monitoring Centre for Drugs and Drug Addiction |
| ORCID | 0000-0001-7681-5933 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings
Australian National Health and Medical Research Council
The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated
Australian National Health and Medical Research Council
Prevalence of drug use before and during imprisonment in seven European countries (2014–2018)
Substance use is a global phenomenon that is particularly affecting the prison population. This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. Individual data collection was carried out between 2014 and 2018 with a model European Questionnaire on Drug Use among people in prison. A total of 12,918 …
Prevalence of illicit drug use before imprisonment in Europe
Current data on the prevalence of prior illicit drug use among the prison population in Europe is scarce. The aim of this study is to identify the prevalence of illicit drug use prior to incarceration, as reported by studies conducted in 30 European countries. A comprehensive literature review was conducted from the 5–31 of March 2018 using the databases Cochrane Library, Embase, MEDLINE, PsychINFO and PubMed. After the deletion of duplications, …
Prevention and Control of Covid-19 in Italian Prisons
OPINION article Front. Public Health, 17 September 2020Sec. Infectious Diseases – Surveillance, Prevention and Treatment Volume 8 - 2020 | https://doi.org/10.3389/fpubh.2020.559135
Hepatitis C virus infection in EU/EEA and United Kingdom prisons
HCV burden in prisons remains high, amidst suboptimal levels of interventions. Systematic monitoring at both local and regional levels is warranted, to advance progress towards the elimination of HCV in the region
New psychoactive substances
Unemployment and drug treatment
Patients in long-term maintenance therapy for drug use in Italy
A significant percentage of heroin users in treatment for opiate addiction in the cohort study have characteristics which indicate reasonable integration within broader society. We posit that the combination of effective treatment and a setting of economic prosperity may enhance the social integration of patients with a history of heroin use
Prevalence of drug use before and during imprisonment in seven European countries (2014–2018)
Substance use is a global phenomenon that is particularly affecting the prison population. This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. Individual data collection was carried out between 2014 and 2018 with a model European Questionnaire on Drug Use among people in prison. A total of 12,918 …
Patients in long-term maintenance therapy for drug use in Italy
A significant percentage of heroin users in treatment for opiate addiction in the cohort study have characteristics which indicate reasonable integration within broader society. We posit that the combination of effective treatment and a setting of economic prosperity may enhance the social integration of patients with a history of heroin use
Unemployment and drug treatment
New psychoactive substances
Prevention and Control of Covid-19 in Italian Prisons
OPINION article Front. Public Health, 17 September 2020Sec. Infectious Diseases – Surveillance, Prevention and Treatment Volume 8 - 2020 | https://doi.org/10.3389/fpubh.2020.559135
Hepatitis C virus infection in EU/EEA and United Kingdom prisons
HCV burden in prisons remains high, amidst suboptimal levels of interventions. Systematic monitoring at both local and regional levels is warranted, to advance progress towards the elimination of HCV in the region
Prevalence of illicit drug use before imprisonment in Europe
Current data on the prevalence of prior illicit drug use among the prison population in Europe is scarce. The aim of this study is to identify the prevalence of illicit drug use prior to incarceration, as reported by studies conducted in 30 European countries. A comprehensive literature review was conducted from the 5–31 of March 2018 using the databases Cochrane Library, Embase, MEDLINE, PsychINFO and PubMed. After the deletion of duplications, …
Prevalence of drug use before and during imprisonment in seven European countries (2014–2018)
Substance use is a global phenomenon that is particularly affecting the prison population. This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. Individual data collection was carried out between 2014 and 2018 with a model European Questionnaire on Drug Use among people in prison. A total of 12,918 …
Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings
Australian National Health and Medical Research Council
The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated
Australian National Health and Medical Research Council
Medicine (7 works) · Drug (6 works) · HIV, Drug Use, Sexual Risk (6 works) · Environmental health (5 works) · Political science (4 works) · Population (4 works) · Psychiatry (4 works) · Psychology (4 works) · Public health (4 works) · Criminal Justice and Corrections Analysis (3 works)